Opening on March 24, 2025, Marks a New Era in Personalized Medicine
TROY, Mich. — March 11, 2025 — MediVera Compounding Pharmacy™, a leader in personalized medicine for over 25 years, is excited to announce the grand opening of its new, state-of-the-art facility located at 5225 Crooks Rd, Troy, MI 48098. Operations at the new location will commence on Monday, March 24, 2025, at 9:00 AM, with customers welcome to pick up their prescriptions from that time forward.
To facilitate the move, MediVera™ will be closed on Friday, March 21, 2025. Normal business hours will resume at the new facility on Monday, March 24.
The new 56,000-square-foot facility is designed to enhance MediVera’s commitment to quality and innovation in compounding pharmacy services. We welcome the public to celebrate with us at our grand opening event on May 1, 2025, from 11:00 AM to 1:00 PM at our new location. Guests will have the opportunity to tour the facility and meet our team. The new building is equipped with advanced ISO-7 cleanrooms and ISO-5 hoods. These features ensure compliance with USP 795, 797, and 800 regulations. These state-of-the-art sterile and non-sterile compounding suites are designed to meet stringent regulatory standards for the preparation of both hazardous and non-hazardous compounds, following USP 795, 797, and 800 guidelines.
“The opening of this facility represents a significant milestone for MediVera™, our employees, and the healthcare providers we serve,” said Bradley McCloskey, PharmD, CEO of MediVera Compounding Pharmacy™. “This investment in cutting-edge technology and compliance ensures that we continue to provide the highest level of quality and service in the industry. We remain committed to exceeding expectations in personalized medicine and patient care.”
MediVera™ employs a dedicated team of 120 professionals, including nine compounding pharmacists, all focused on delivering personalized care. The company invests $30,000 monthly in third-party testing to ensure all formulations meet and exceed standards for potency and sterility. MediVera Compounding Pharmacy™ is PCAB-accredited in both sterile and non-sterile pharmacy compounding—a distinction held by fewer than 1% of pharmacies. The American Medical Association (AMA) recommends physicians only use PCAB-accredited compounding pharmacies.
Licensed to operate in and ship to 43 states, MediVera™ continues to expand its reach, bringing personalized medicine to patients nationwide. Our proprietary customer service program, The Impressed Advantage by MediVera Compounding Pharmacy™, delivers fast shipping, dedicated account management, and ongoing education for providers while also enhancing patient support. We simplify prescription fulfillment so patients can focus on their health—contacting each patient within one business day, answering most calls within 30 seconds, and shipping most compounds within 48 hours of confirmation. The new facility in Troy represents a major step forward in our mission to provide exceptional, customized pharmaceutical care.
43 States: AK, AZ, CO, CT, DE, FL, GA, ID, IL, IA, IN, KS, KY, LA, ME, MD, MA, MI, MN, MO, MT, NE, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, UT, VA, VT, WA, WV, WI, WY.
About MediVera Compounding Pharmacy™
Founded in 1999, MediVera Compounding Pharmacy™ has been at the forefront of personalized medicine, offering tailored pharmaceutical solutions to meet the unique needs of healthcare providers and patients. With a focus on quality, safety, and customer satisfaction, MediVera™ continues to set industry standards in compounding pharmacy services.
